|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts, notes and other receivables – net (Note 6) | ||||||||||||||||||||
| Inventories – net (Note 8) | ||||||||||||||||||||
| Other current assets (Note 9) | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Investments and long-term receivables | ||||||||||||||||||||
| Property, plant and equipment – net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other assets (Note 10) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Current maturities of long-term debt (Note 15) | ||||||||||||||||||||
| Accrued liabilities (Note 12) | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt (Note 15) | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other liabilities (Note 13) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| EQUITY (DEFICIT) | ||||||||||||||||||||
| Series A Preferred Stock, par value $0.001; 0 and 245,089,671 shares issued and outstanding as of December 31, 2023 and 2022, respectively (Note 21) | ||||||||||||||||||||
| Common Stock, par value $0.001; 1,000,000,000 and 1,000,000,000 shares authorized, 245,457,621 and 242,549,685 issued and 186,800,685 and 190,556,297 outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid–in capital | ||||||||||||||||||||
| Retained deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss (Note 18) | ||||||||||||||||||||
| Treasury Stock, at cost; $58,666,936 and 51,993,388 shares as of June 30, 2026 and December 31, 2025, respectively (Note 16) | ||||||||||||||||||||
| Total deficit | ||||||||||||||||||||
| Total liabilities and deficit | ||||||||||||||||||||
| Preferred stock, shares issued (in shares) | ||||||||||||||||||||
Loading...